Laboratory identification of lupus anticoagulants

American Journal of Hematology

Volumn 84, Issue 7, 2009, Pages 440-442

  Smock, Kristi J ^a   Rodgers, George M ^a,b  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUPUS ANTICOAGULANT;

BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; HUMAN; LABORATORY TEST; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; VEIN THROMBOSIS;

BLOOD COAGULATION TESTS; CLINICAL LABORATORY TECHNIQUES; HUMANS; LUPUS COAGULATION INHIBITOR;

EID: 67649697309     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21417     Document Type: Review

References (23)

1. Rodgers GM. Acquired coagulation disorders. In: Greer JP, Foerster J, Rodgers GM, et al., editors. Wintrobe's Clinical Hematology. Philadelphia: Lippincott Williams & Wilkins; 2009. pp1425-1463.
2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
3. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/ Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995;74:1185-1190.
4. Wong RC, Adelstein S, Gillis D, et al. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing. Semin Thromb Hemost 2005;31:39-48. (Pubitemid 40262136)
5. Abo SM, DeBari VA. Laboratory evaluation of the antiphospholipid syndrome. Ann Clin Lab Sci 2007;37:3-14. (Pubitemid 46310993)
6. Hoppensteadt DA, Fabbrini N, Bick RL, et al. Laboratory evaluation of the antiphospholipid syndrome. Hematol Oncol Clin North Am 2008;22:19-32.
7. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002;126: 1424-1429. (Pubitemid 36237295)
8. Giannakopoulos B, Passam F, Ioannou Y, et al. How we diagnose the antiphospholipid syndrome. Blood 2009;113:985-994.
9. Pengo V, Biasiolo A, Gresele P, et al. A comparison of lupus anticoagulantpositive patients with clinical picture of antiphospholipid syndrome and those without. Arterioscler Thromb Vasc Biol 2007;27:e309-310. (Pubitemid 350158938)
10. Tripodi A. Laboratory testing for lupus anticoagulants: A review of issues affecting results. Clin Chem 2007;53:1629-1635. (Pubitemid 47340059)
11. Teruya J, West AG, Suell MN. Lupus anticoagulant assays: Questions answered and to be answered. Arch Pathol Lab Med 2007;131:885-889. (Pubitemid 46906379)
12. Moffat KA, Ledford-Kraemer MR, Plumhoff EA, et al. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost 2009;101:178-184.
13. Tripodi A, Biasiolo A, Chantarangkul V, et al. Lupus anticoagulant (LA) testing: Performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clin Chem 2003;49: 1608-1614. (Pubitemid 37194214)
14. Zhang L, Whitis JG, Embry MB, et al. A simplified algorithm for the laboratory detection of lupus anticoagulants: Utilization of two automated integrated tests. Am J Clin Pathol 2005;124:894-901. (Pubitemid 41740190)
15. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol 1991;44:885-889.
16. Greaves M, Cohen H, MacHin SJ, et al. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000;109: 704-715. (Pubitemid 30609746)
17. Pengo V, Biasiolo A, Gresele P, et al. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost 2007;5: 925-930. (Pubitemid 46691720)
18. Chang S. More on: Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J Thromb Haemost 2004;2:1480-1481. (Pubitemid 40186151)
19. Moore GW, Savidge GF. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res 2006;118:523-528. (Pubitemid 44292799)
20. Moore GW, Henley A, Greenwood CK, et al. Further evidence of false negative screening for lupus anticoagulants. Thromb Res 2008;121:477-484. (Pubitemid 351174269)
21. Genzen JR, Miller JL. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing. Am J Clin Pathol 2005;124:586-593. (Pubitemid 41395640)
22. Gosselin RC, King JH, Janatpur KA, et al. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. Arch Pathol Lab Med 2004;128:1142-1145. (Pubitemid 39313368)
23. Jennings I, Mackie I, Arnout J, et al. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: Performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2004;2:2178-2184. (Pubitemid 40185779)